KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Cost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Clover Health Investments (CLOV) Cost of Revenue (2020 - 2025)

Clover Health Investments' Cost of Revenue history spans 6 years, with the latest figure at $413.5 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 70.13% year-over-year to $413.5 million; the TTM value through Dec 2025 reached $1.6 billion, up 55.85%, while the annual FY2025 figure was $1.6 billion, 55.85% up from the prior year.
  • Cost of Revenue reached $413.5 million in Q4 2025 per CLOV's latest filing, down from $423.5 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $861.7 million in Q1 2022 to a low of -$1.6 billion in Q4 2022.
  • Average Cost of Revenue over 5 years is $288.1 million, with a median of $274.8 million recorded in 2023.
  • The largest YoY upside for Cost of Revenue was 451063.35% in 2022 against a maximum downside of 454.63% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $441.9 million in 2021, then crashed by 454.63% to -$1.6 billion in 2022, then skyrocketed by 115.94% to $249.8 million in 2023, then fell by 2.69% to $243.0 million in 2024, then skyrocketed by 70.13% to $413.5 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Cost of Revenue are $413.5 million (Q4 2025), $423.5 million (Q3 2025), and $378.0 million (Q2 2025).